Home » Topics » Regulatory » Patents

Patents
RSS

Boehringer Mannheim reports fibrinogen antagonists for thromboembolic conditions

Oct. 4, 1996

HLE inhibitors described by Zeneca

Oct. 4, 1996

Natural cAMP phosphodiesterase inhibitor reported by Nippon Kayaku

Oct. 4, 1996

Zeneca claims new antiasthma agents

Oct. 4, 1996

Calpain inhibitors from Fujirebio

Oct. 4, 1996

Astra NOS inhibitors as neuroprotectants

Oct. 4, 1996

Spanish investigators report MAO inhibitors

Oct. 4, 1996

New antipsychotic agents from Janssen

Oct. 4, 1996

5-HT2B/2C antagonists disclosed by SKB

Oct. 4, 1996

Novel benzodiazepine derivatives from Roche

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...